New Results

dearseq: a variance component score test for RNA-Seq differential analysis that effectively controls the false discovery rate

Marine Gauthier, Denis Agniel, Rodolphe Thiébaut, Boris P. Hejblum
doi: https://doi.org/10.1101/635714

Article Information

doi 
https://doi.org/10.1101/635714
History 
  • May 20, 2019.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Marine Gauthier1,2,
  2. Denis Agniel3,4,
  3. Rodolphe Thiébaut1,2,5 and
  4. Boris P. Hejblum1,2,*
  1. 1University of Bordeaux, INSERM Bordeaux Population Health Research Center, IN-RIA SISTM, F-33000 Bordeaux, France
  2. 2Vaccine Research Institute, F-94000 Créteil, France
  3. 3Rand Corporation, Santa Monica (CA), USA
  4. 4Harvard Medical School, Boston (MA), USA
  5. 5CHU de Bordeaux, Bordeaux, F-33000 France
  1. ↵*Corresponding author; email: boris.hejblum{at}u-bordeaux.fr
Back to top
Posted May 20, 2019.
Download PDF

Supplementary Material

Data/Code
Email
dearseq: a variance component score test for RNA-Seq differential analysis that effectively controls the false discovery rate
Marine Gauthier, Denis Agniel, Rodolphe Thiébaut, Boris P. Hejblum
bioRxiv 635714; doi: https://doi.org/10.1101/635714
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area